CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced that data from a proof-of-concept study exploring two potential oral therapeutic candidates for the treatment of patients with OSA, AD504 (atomoxetine + trazodone) and AD182, will be featured in an oral presentation at SLEEP 2022 in Charlotte, NC, on Monday, June 6. SLEEP 2022 is the 36th annual meeting of the Associated Professional Sleep Societies (APSS), a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).
A generic drugmaker with a Rolodex full of federal clients is pulling an antidepressant and an erectile dysfunction med after the two were packaged together in the same bottles.
AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone
Any number of issues can lead to an FDA recall, but here’s one you don’t see every day: A third-party manufacturer for Tennessee-based AvKARE apparently mixed an antidepressant and erectile dysfunction med into the same packaging, creating a potent — if accidental — mix for patients.
Of course, everyone knows that when you break your leg you go to the emergency room. If you have a bacterial infection, you’re usually prescribed antibiotics. There’s even medication for mental health issues like depression and anxiety. But what are you supposed to do when you have a low sex drive?
Zydus Pharm’s Generic Trazodone Hydrochloride Receives Approval In US
Accord’s Generic Trazodone Hydrochloride Receives Approval In US
Angelini Fine Chemicals: new synthesis technologies to broaden the offer